Comments
Halozyme shares dive after FDA asks for more drug data
02.08.2012. | (Reuters) - Regulators have asked for additional animal test data before considering Halozyme Therapeutics Inc's application for an injected version of Baxter International Inc's treatment for immune deficiency disorders....
